Mycophenolate mofetil , 98% , 128794-94-5
| Pack Size | Price | Stock | Quantity |
| 250MG | RMB118.40 | In Stock |
|
| 1G | RMB273.60 | In Stock |
|
| 5G | RMB886.40 | In Stock |
|
| 25g | RMB2552.00 | In Stock |
|
| 100g | RMB7598.40 | In Stock |
|
| others | Enquire |
PRODUCT Properties
| Melting point: | 95-96°C |
| Boiling point: | 637.6±55.0 °C(Predicted) |
| Density | 1.222±0.06 g/cm3(Predicted) |
| storage temp. | room temp |
| solubility | DMSO: ≥15mg/mL |
| pka | 5.6(at 25℃) |
| form | powder |
| color | white to beige |
| Merck | 14,6327 |
| Stability: | Stable for 2 years from date of purchase as supplied. Solutions in DMSO or ethanol may be stored at -20° for up to 1 month. |
| InChIKey | RTGDFNSFWBGLEC-SYZQJQIISA-N |
Description and Uses
Mycophenolate mofetil was launched in 1995 in the U.S.A., its first market worldwide, for the prevention of acute kidney transplant rejection in conjunction with other immunosuppressive therapy and to treat refractory acute kidney graft rejection. With improved oral absorption and bioavailability, mycophenolate mofetil is a prodrug of mycophenolic acid (MPA), a fermentation product of several Penicillium species. MPA is a selective, reversible, non-competitive inhibitor of inosinate dehydrogenase and guanylate synthetase. It inhibits the de now pathway of purine biosynthesis. MPA was found to have more potent antiproliferative effects on T and B lymphocytes than other cell types. Compared with other immunosuppressants, mycophenolate mofetil is reportedly superior due to its unique mechanism of action and excellent safety profile for long term use. Mycophenolate mofetil is being investigated clinically in the treatment of heart and liver transplantation rejection, asthma, in preventing coronary artery restenosis, and in treating rheumatoid arthritis.
An immunosuppressant.
Safety
| Symbol(GHS) |    GHS07,GHS08,GHS09 |
| Signal word | Danger |
| Hazard statements | H302-H360D-H372-H410 |
| Precautionary statements | P202-P260-P264-P273-P301+P312-P308+P313 |
| Hazard Codes | Xn |
| Risk Statements | 22 |
| Safety Statements | 22-24/25 |
| RIDADR | UN 3077 9 / PGIII |
| WGK Germany | 3 |
| RTECS | MP7746700 |
| HS Code | 29349990 |
